Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 2 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Recs

0
Player Avatar saunafool (98.66) Submitted: 10/5/2012 10:13:04 AM : Outperform Start Price: $6.41 SGMO Score: +35.06

Speculative bet of Biomed stock with what appears to be a different approach from others. Not a real money pick and I know nothing about biomed.

Featured Broker Partners


Advertisement